Stay updated on SOUL Study: Semaglutide in Diabetes Clinical Trial
Sign up to get notified when there's something new on the SOUL Study: Semaglutide in Diabetes Clinical Trial page.

Latest updates to the SOUL Study: Semaglutide in Diabetes Clinical Trial page
- Check3 days agoChange DetectedRevision history updated to include v3.3.4 and remove v3.3.3 for the study record NCT03914326. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA new Revision: v3.3.3 entry was added to the history, and the HHS Vulnerability Disclosure link and the Revision: v3.3.2 entry were removed.SummaryDifference0.0%

- Check32 days agoChange DetectedDifference0.1%

- Check54 days agoChange DetectedAdded revision v3.3.2 and removed revision v3.2.0 from the Record History.SummaryDifference0.0%

- Check61 days agoChange DetectedThe government funding lapse notice was removed from the page. This is a minor editorial update.SummaryDifference0.2%

- Check75 days agoChange DetectedThe two screenshots show the same Record History page with no visible changes to core study information; only version history entries are listed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to SOUL Study: Semaglutide in Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SOUL Study: Semaglutide in Diabetes Clinical Trial page.